Early Access — free while we kick the tires
EdgarHawk

Sander Dale A.

CFO and Chief Corp. Deve. Off.

Officer
1 filing analyzed · 1 company · Latest 2025-04-14

Never miss a filing from Sander Dale A.

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Humacyte, Inc. HUMA 1 0 Net buying

Activity

April 2025
2025-04-14 Humacyte, Inc. HUMA
high
Buy
20,000 shares
$30,600
Significance 7/10

CFO Sander Dale A. bought 20,000 shares of HUMA at $1.53; stock down 84.2% from 52-week high; 5 other insiders also bought within 14 days.

CFO Sander Dale A. purchased 20,000 shares at $1.53 on 2025-04-10, doubling his stake from 20,600 to 40,600 shares. This buy occurs after the stock has fallen 84.2% from its 52-week high of $9.46 and is down 51.0% over the past 30 days and 63.8% over 90 days. Notably, 5 other insiders also bought within the past 14 days, forming a cluster buy pattern. The company posted a net loss of $39.2M in the most recent fiscal year against quarterly revenue of $241.0K, indicating material operating losses and cash burn concerns. The insider purchases at depressed price levels combined with simultaneous buying by multiple executives warrant attention as a potential capitulation or contrarian signal, though the company's negative profitability trajectory remains a fundamental headwind.

Related insiders